News Overview

Larsen Toubro Infotech has allotted 14320 equity shares under ESOS on 28 February 2022

Bharat Electronics has received a contract from Ministry of Defence Govt of India for the retro-modification of Commander Sight of Battle Tanks-T90 for the Indian Army The retro-modification will be carried out in 957 tanks The total value of the contract is Rs 1075 crore including all taxes and duties

The Board of Vipul Organics at its meeting held on 28 February 2022 has approved issuance of bonus equity shares in ratio of 14 The Board also approved increase in authorised share capital from Rs 1050 crore to Rs 1350 crore The Board also allotted 334000 equity shares on conversion of warrants

Infibeam Avenues announced that Hiren Padhya Chief Financial Officer and Key Managerial Personnel of the Company has resigned from the position

Punjab National Bank announced that Anil Kumar Misra has been appointed as a Govt Nominee Director of the Bank in place of Vivek Aggarwal

Zen Technologies has been awarded an export contract for the supply of training equipment worth Rs 1350 crore As of date the companys total order book stands at Rs 42856 crore comprising of export orders worth Rs 17226 crore

Ugro Capital has approved the issuance of rated secured senior listed transferable redeemable non-convertible debentures for an amount of Rs50 crore Base Issue Size with an option to retain over-subscription upto Rs 50 crore aggregating up to Rs 100 Crore Overall Issue Size though public issue

Ducon Infratechnologies has announced a bonus issue of 1 share for ever 10 shares The Board of the company also approved an increase in authorised share capital from Rs 25 crore to Rs 30 crore

Mastek has allotted 4225 equity shares on 27 February 2022 under ESOP Consequently the paid up equity share capital has increased to 30002952 equity shares of Rs 5 each aggregating to Rs 150014760

Biocon Biologics a subsidiary of Biocon announced today that it has entered into a definitive agreement with its partner Viatris Inc NASDAQ VTRS Accordingly Biocon Biologics BBL will acquire Viatris biosimilars business to create a unique fully integrated global biosimilars enterprise Viatris will receive consideration of up to USD 3335 billion including cash up to USD 2335 billion and Compulsorily Convertible Preference Shares CCPS in […]